24.63
-0.50 (-1.99%)
| Previous Close | 25.13 |
| Open | 25.58 |
| Volume | 3,331,925 |
| Avg. Volume (3M) | 1,511,315 |
| Market Cap | 2,171,343,360 |
| Price / Book | 3.26 |
| 52 Weeks Range |
| Diluted EPS (TTM) | -3.75 |
| Current Ratio (MRQ) | 26.48 |
| Operating Cash Flow (TTM) | -192.66 M |
| Levered Free Cash Flow (TTM) | -122.17 M |
| Return on Assets (TTM) | -35.87% |
| Return on Equity (TTM) | -56.31% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bullish | Mixed |
| Biotechnology (Global) | Bullish | Mixed | |
| Stock | Mineralys Therapeutics, Inc. | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | 2.0 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | -2.5 |
| Average | 0.63 |
|
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Growth |
| % Held by Insiders | 1.40% |
| % Held by Institutions | 103.83% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Catalys Pacific, Llc | 31 Mar 2026 | 7,903,838 |
| Andera Partners | 31 Mar 2026 | 1,591,917 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |